News & Perspective

Nov 22, 2006

Nov 22, 2006

Salmonella enteritidis on the rise in chickens

(CIDRAP News) – Sampling by the US Department of Agriculture (USDA) over the last 5 years has shown a fourfold increase in the number of broiler chicken carcasses contaminated with Salmonella enterica serotype enteritidis, a strain previously associated mainly with eggs.

Nov 22, 2006

Nov 22, 2006

How's Your Business Discontinuity Program?

More and more companies are starting to integrate pandemic preparedness into their business continuity programs. That's good news--and helping to facilitate it is one of the reasons this newsletter was launched.

Nov 22, 2006

Reports show difficulty of diagnosing H5N1 cases

(CIDRAP News) – Two new reports on human cases of H5N1 avian influenza that occurred in Turkey and Indonesia last year show that the illness proved difficult to diagnose, with many tests yielding false-negative results.

Nov 21, 2006

Nov 21, 2006

Study finds 2 mutations that help H5N1 infect humans

(CIDRAP News) – Researchers recently reported identifying two mutations in the H5N1 avian influenza virus that seem to improve its ability to attach to human cells, a finding that may help scientists spot H5N1 strains capable of infecting humans.

Nov 20, 2006

Nov 20, 2006

HHS issues planning guide for mass casualty events

(CIDRAP News) – The Department of Health and Human Services (HHS) has released a new medical care guide to help community leaders plan for and respond to mass casualty events such as an influenza pandemic or a terrorist nuclear attack.

Nov 20, 2006

HHS awards 3 contracts for more H5N1 vaccine

(CIDRAP News) – The US government today announced the awarding of three contacts to buy enough additional H5N1 avian influenza vaccine to immunize almost 2.7 million people, at a cost of $199.45 million.

Nov 17, 2006

Nov 17, 2006

FluMist called safe, effective for kids with asthma

(CIDRAP News) – For children and adolescents with asthma, the intranasal influenza vaccine FluMist was as safe as and more effective than an injectable vaccine in a phase 3 trial of young people aged 6 to about 17 years.

The study, which involved 2,229 children at 145 sites in 12 European countries and Israel, was published in the October issue of The Pediatric Infectious Disease Journal.

Nov 17, 2006

HHS: Most H5N1 vaccine on hand is still potent

(CIDRAP News) – A Department of Health and Human Services official said today that loss of potency is affecting less than 20% of H5N1 avian influenza vaccine doses in the national stockpile, not a majority of doses as reported here yesterday.

Bill Hall, an HHS spokesman in Washington, DC, said the agency has acquired a total of about 7.5 million doses of H5N1 vaccine to date, and about 200,000 of those have been used for research.

Nov 16, 2006

Nov 16, 2006

HHS says stockpiled H5N1 vaccine is losing potency

Editor's note: The day after publication of this story, a federal official told CIDRAP News the amount of H5N1 vaccine in the US stockpile that had begun to lose potency was less than 20% of the total, not a majority of the doses. See the Nov 17 follow-up story for more details.

Nov 16, 2006

Clinicians raise questions about respirator use in pandemic

(CIDRAP News) – Last month the US Department of Health and Human (HHS) called for a greater role for N95 respirators in protecting healthcare workers in the event of an influenza pandemic, and now clinicians are raising questions about potential problems such as inadequate supplies and poor fit.

Pages

Sort Results

 

Narrow results

by Topic

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M Gilead 
Grant support for ASP provided by

  Become an underwriter»